Table 3.
Type of Cancer | Expression Testing Method | Impact on Survival at High CXCL1 Expression | Number of Patients in the Study | Notes | Source |
---|---|---|---|---|---|
Cervical cancer: uterine corpus endometrial carcinoma | Microarray GEPIA/TCGA database |
No significant impact on prognosis | 172 | OS, DFS based on the GEPIA database |
[110] |
DFS—disease-free survival; OS—overall survival.